Inventor
AKIRA TANOKURA
Inventor
JP
Overview
Patents· 3 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes23%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations23%
C07KPeptides23%
C12NMicroorganisms or enzymes15%
A01KAnimal husbandry8%
G01NInvestigating or analysing materials by determining their chemical or physical properties8%
PatentTitleYear
12,227,563Anti-IGF-I receptor humanized antibody202511,739,143Humanized antibody for treating or preventing cognitive disorders, process for producing the same, and agent for treating or preventing cognitive disorders using the same202311,629,194Anti-IGF-I receptor antibodies, encoding nucleic acid molecules and methods of using said antibodies2023Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2023–2025Patents assigned to TEIJIN PHARMA LTD (3)· patent assignee history
2023Patents assigned to MERCK SHARP & DOHME (1)· patent assignee history
2023Patents assigned to MERCK SHARP & DOHME LLC (1)· patent assignee history
2023–2025Based in JP· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| TEIJIN PHARMA LTD | 3 | 2023–2025 |
| MERCK SHARP & DOHME | 1 | 2023 |
| MERCK SHARP & DOHME LLC | 1 | 2023 |
Locations
| Location | Patents | Span |
|---|---|---|
| JP | 3 | 2023–2025 |